Carlos Cordon-Cardo
Carlos Cordon-Cardo (pronunciation: Car-los Cor-don Car-do) is a renowned pathologist and oncologist known for his significant contributions to the field of cancer research.
Etymology
The name "Carlos" is of Spanish origin, meaning "free man". "Cordon-Cardo" is a hyphenated surname common in Spanish-speaking countries. The term "Cordon" is derived from the French word for "ribbon", while "Cardo" is a Spanish word for "thistle".
Career
Carlos Cordon-Cardo is currently the Irene Heinz Given and John LaPorte Given Professor and Chair of the Department of Pathology at the Mount Sinai Health System. He is also the Director of the Molecular Oncology Program at the Tisch Cancer Institute. His research primarily focuses on the molecular mechanisms of human cancer, including the role of tumor suppressor genes and oncogenes.
Contributions
Cordon-Cardo has made significant contributions to the understanding of the molecular pathogenesis of human cancers. He is known for his work on the multidrug resistance (MDR) phenotype in human cancer, which has led to the development of new therapeutic strategies. He has also contributed to the identification and characterization of cancer stem cells, which has had a profound impact on the field of cancer biology.
Related Terms
- Pathology
- Oncology
- Cancer
- Tumor suppressor genes
- Oncogenes
- Cancer stem cells
- Molecular Oncology
- Mount Sinai Health System
- Tisch Cancer Institute
External links
- Medical encyclopedia article on Carlos Cordon-Cardo
- Wikipedia's article - Carlos Cordon-Cardo
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski